Navigation Links
Aspirin use appears linked with improved survival after colon cancer diagnosis
Date:3/31/2014

Bottom Line: Taking low doses of aspirin (which inhibits platelet function) after a colon cancer diagnosis appears to be associated with better survival if the tumor cells express HLA class I antigen.

Author: Marlies S. Reimers, M.D., Leiden University Medical Center, the Netherlands, and colleagues.

Background: Prior research has suggested aspirin use after a colorectal cancer diagnosis might improve survival. Although the precise mechanism of aspirin's anti-cancer effect is unknown, previous data suggest that aspirin may prevent distant metastasis in colorectal cancer.

How the Study Was Conducted: The study examined tissue from tumors from 999 patients with colon cancer who underwent surgery between 2002 and 2008. Tissue samples were examined for HLA class I antigen and prostaglandin endoperoxide synthase 2 (PTGS2). Most patients had colon cancer diagnosed at stage III or lower. Data on aspirin use (defined as patients given a prescription for aspirin for 14 days or more after colon cancer diagnosis) came from a prescription database.

Results: Of the 999 patients, 182 (18.2 percent) were aspirin users and among them there were 69 deaths (37.9 percent). There were 396 deaths among 817 nonusers of aspirin (48.5 percent). Aspirin use after colon cancer diagnosis was associated with improved overall survival compared with nonuse. The potential survival benefit of aspirin was strongest among patients with HLA I antigen expression. The molecular reasons underlying the effects of aspirin are not completely understood, but the authors suggest the results are likely the effect of aspirin on circulating tumor cells and their ability to develop into metastatic deposits.

Discussion: "We found that the survival benefit associated with low-dose aspirin use after a diagnosis of colon cancer was significantly associated with
'/>"/>

Contact: Gerrit Jan Liefers
g.j.liefers@lumc.nl
The JAMA Network Journals
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Report says new evidence could tip the balance in aspirin cancer prevention care
2. Aspirin as Effective as Warfarin for Heart Failure: Study
3. Some Diabetics May Not Benefit From Daily Aspirin
4. Aspirin protects against Barretts esophagus
5. Study adds to evidence daily aspirin linked to lower cancer mortality
6. Daily aspirin usage associated with lower cancer mortality
7. Daily Aspirin May Cut Cancer Deaths, Another Study Finds
8. Daily Aspirin May Help Fight Prostate Cancer, But Not Breast Cancer
9. Aspirin may help men with prostate cancer live longer, study suggests
10. Adding Plavix to Aspirin Doesnt Help Guard Against Second Stroke: Study
11. Gene mutation identifies colorectal cancer patients who live longer with aspirin therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... (PRWEB) , ... September 03, 2015 , ... ... included Intellicure, Inc., in its Annual Inc. 5000 list of fastest-growing private ... that "only a tiny fraction of the nation's companies have demonstrated such remarkably ...
(Date:9/3/2015)... ... , ... According to an Oncology Nurse Advisor article published on ... oropharyngeal cancer (oral cancer) to be successfully diagnosed and treated for relapses of the ... which have a high rate of success in treatment and elimination of the disease; ...
(Date:9/3/2015)... , ... September 03, 2015 , ... ... 2015: DiabetesSisters is pleased to announce the additional of Carol Wysham, MD, to ... current board members Diana Karczmarczyk, Donna Rice, David Warren, Matt Stella, Tricia Cedotal, ...
(Date:9/3/2015)... ... September 03, 2015 , ... “We ... which can impact the delicate life balance between work and leisure to the ... Jeffrey R. Leaptrott, CEO , A LifeMinder Plus® Emergency Care Document Set duly ...
(Date:9/3/2015)... ... , ... Mum n Me is pleased to announce the launch of its ... gives maximum protection from sun exposure, wind, bugs, and germs. The Mum n Me ... by keeping the cover securely in place. The new car seat cover is made ...
Breaking Medicine News(10 mins):Health News:Inc. 5000 Includes Intellicure, Inc., Two Years in a Row 2Health News:LA Periodontists Discuss Study on Post-Treatment Oral Rinses Used to Test Recurrence of Oral Cancers 2Health News:LA Periodontists Discuss Study on Post-Treatment Oral Rinses Used to Test Recurrence of Oral Cancers 3Health News:Carol H. Wysham, MD, Joins DiabetesSisters Board of Directors 2Health News:LifeMinder Plus® Announces Emergency Care Document Set Giveaway for America 2Health News:LifeMinder Plus® Announces Emergency Care Document Set Giveaway for America 3Health News:Mum n Me Announces New Baby Car Seat Cover 2
... Rare Town Hall Meeting With U.S. Senator Arlen Specter ... CostsPHILADELPHIA, Feb. 18 AARP Pennsylvania, Business Roundtable, National ... Union held a town hall meeting today on the ... in Philadelphia at the National Constitution Center. While in ...
... New research finds misdiagnosis risk goes up as age goes ... boy complaining of numbness at a Detroit emergency room was ... A 24-year-old woman with sharp pain in her left eye ... by ER doctors that she had a migraine. , And ...
... letter to be published in this week,s Journal ... S. Stanley Young, Assistant Director of Bioinformatics at the ... of British Columbia, highlight the statistical limitations of a ... diabetes and abnormal blood level liver,enzyme levels. The earlier ...
... Monthly menstrual cycles produce many ... cramps, headaches and bloating. With more intense, painful ... vomiting also is a symptom. This monthly recurrence ... study in the November/December 2008 issue of General ...
... (2/18/2009) -- Autism Speaks today announced initial results ... Autism Clinical Trials Network (ACTN), the Study of ... fluoxetine was not effective for reducing repetitive behaviors ... compared to placebo (non-medicinal sugar pill). The study ...
... CRH Medical announced today that for the year ended December ... for Colorectal Health compared to 13,461 for the same period ... Program, the Company sold 6,840 units of its CRH O,Regan ... in 2007. The Company trained more than 100 physicians in ...
Cached Medicine News:Health News:Divided We Fail Pushes to Keep Health Care Reform as a Top Priority for Congress and the New Administration 2Health News:Divided We Fail Pushes to Keep Health Care Reform as a Top Priority for Congress and the New Administration 3Health News:ER Less Likely to Diagnose Stroke in Younger Folks 2Health News:ER Less Likely to Diagnose Stroke in Younger Folks 3Health News:Women Only: Cramps, Bloating and Now, Tooth Erosion? 2Health News:Women Only: Cramps, Bloating and Now, Tooth Erosion? 3Health News:Autism Speaks reports Neuropharm's SOFIA results 2Health News:Autism Speaks reports Neuropharm's SOFIA results 3Health News:CRH experiences significant increase in business activity 2
(Date:9/3/2015)... Sept. 3, 2015  VirtualScopics, Inc. (NASDAQ: ... imaging solutions, announced today, they are collaborating with ... new philanthropic, epidemiology study partnering with the Ministry ...  VirtualScopics has teamed up with a cardiac sonographer ... image results will be used to identify children ...
(Date:9/3/2015)... Sept. 3, 2015 Research and Markets ( ... "Investigation Report on China Olmesartan Market, 2010-2019" report ... medoxomil was successfully developed by Sankyo Pharmaceuticals Co., Ltd ... olmesartan medoxomil was approved by FDA to enter the ... best- selling drug in the world after it succeeded ...
(Date:9/3/2015)... , Sep. 03, 2015 ... ) has announced the addition of the ... 2010-2019" report to their offering. ... totally different chemical structure from steroids which ... can also provide analgestic and antipyretic effects ...
Breaking Medicine Technology:VirtualScopics, Inc. Collaborates with Large Pharmaceutical Company on a Philanthropic, Epidemiology Study in Africa 2VirtualScopics, Inc. Collaborates with Large Pharmaceutical Company on a Philanthropic, Epidemiology Study in Africa 3VirtualScopics, Inc. Collaborates with Large Pharmaceutical Company on a Philanthropic, Epidemiology Study in Africa 4China Olmesartan Investigation Market Report 2010-2019 2China Flurbiprofen Market Investigation Report 2010-2019 2
... of evaluable heavily-pretreated patients in the high dose ... tolerated overall.DALLAS, March 5 ACCESS PHARMACEUTICALS, ... safety and efficacy results from its Phase 2 ... heavily pretreated ovarian cancer patients. In this monotherapy ...
... March 4 A new study by researchers at ... essential B vitamins, including B6, B12, and folic acid, ... of the leading causes of vision loss among older ... key omega-3 fatty acids and phytosterols, are also contained ...
Cached Medicine Technology:Access Pharmaceuticals Announces Positive ProLindac(TM) Phase 2 Ovarian Cancer Clinical Trial Results 2Access Pharmaceuticals Announces Positive ProLindac(TM) Phase 2 Ovarian Cancer Clinical Trial Results 3Access Pharmaceuticals Announces Positive ProLindac(TM) Phase 2 Ovarian Cancer Clinical Trial Results 4Harvard Study Shows Folic Acid, B Vitamins in Animi-3(R) May Prevent Vision Loss 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: